0001662118-19-000001.txt : 20190426
0001662118-19-000001.hdr.sgml : 20190426
20190426123652
ACCESSION NUMBER: 0001662118-19-000001
CONFORMED SUBMISSION TYPE: D/A
PUBLIC DOCUMENT COUNT: 1
ITEM INFORMATION: 06b
FILED AS OF DATE: 20190426
DATE AS OF CHANGE: 20190426
EFFECTIVENESS DATE: 20190426
FILER:
COMPANY DATA:
COMPANY CONFORMED NAME: Petra Pharma Corp
CENTRAL INDEX KEY: 0001662118
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: D/A
SEC ACT: 1933 Act
SEC FILE NUMBER: 021-321233
FILM NUMBER: 19770574
BUSINESS ADDRESS:
STREET 1: 430 EAST 29TH STREET
CITY: NEW YORK
STATE: NY
ZIP: 10016
BUSINESS PHONE: (206) 957-7300
MAIL ADDRESS:
STREET 1: 430 EAST 29TH STREET
CITY: NEW YORK
STATE: NY
ZIP: 10016
D/A
1
primary_doc.xml
X0708
D/A
LIVE
0001662118
Petra Pharma Corp
450 East 29th St., Suite 506
NEW YORK
NY
NEW YORK
10016
(206) 957-7300
DELAWARE
None
None
Corporation
true
2015
Thong
Le
c/o Petra Pharma Corporation
450 E 29th St., Suite 506
New York
NY
NEW YORK
10016
Director
Promoter
Steve
Gillis
c/o Petra Pharma Corporation
450 E 29th St., Suite 506
New York
NY
NEW YORK
10016
Director
M.
Johnston
Erwin
c/o Petra Pharma Corporation
450 E 29th St., Suite 506
New York
NY
NEW YORK
10016
Director
Barbara
Dalton
c/o Petra Pharma Corporation
450 E 29th St., Suite 506
New York
NY
NEW YORK
10016
Director
Jenna
Foger
c/o Petra Pharma Corporation
450 E 29th St., Suite 506
New York
NY
NEW YORK
10016
Director
Paul
Sekhri
c/o Petra Pharma Corporation
450 E 29th St., Suite 506
New York
NY
NEW YORK
10016
Director
Brian
O'Callaghan
c/o Petra Pharma Corporation
450 E 29th St., Suite 506
New York
NY
NEW YORK
10016
Executive Officer
Director
David
McElligott
c/o Petra Pharma Corporation
450 E 29th St., Suite 506
New York
NY
NEW YORK
10016
Executive Officer
Promoter
David
Renas
c/o Petra Pharma Corporation
450 E 29th St., Suite 506
New York
NY
NEW YORK
10016
Executive Officer
Albert
Yu
c/o Petra Pharma Corporation
450 E 29th St., Suite 506
New York
NY
NEW YORK
10016
Executive Officer
Lindsay
Rayle
c/o Petra Pharma Corporation
450 E 29th St., Suite 506
New York
NY
NEW YORK
10016
Promoter
David
Schubert
c/o Petra Pharma Corporation
450 E 29th St., Suite 506
New York
NY
NEW YORK
10016
Promoter
Biotechnology
Decline to Disclose
- 06b
true
0001662118-18-000002
2018-08-30
false
true
true
true
false
0
13343020
13343020
0
false
10
0
0
0
false
Petra Pharma Corp
/s/ David Renas
David Renas
Chief Financial Officer
2019-04-26